pBabe_Hyg_cOVA_T2A_mStrawberry
(Plasmid
#161737)
-
PurposeExpression of cOVA and mStrawberry
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 161737 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepBabe-hygro
-
Backbone manufacturerAddgene #1765
- Total vector size (bp) 7132
-
Vector typeMammalian Expression, Retroviral
-
Selectable markersHygromycin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert namecytoplasmic ovalbumin
-
Alt namecOVA
-
SpeciesG. gallus (chicken)
-
Tag
/ Fusion Protein
- mStrawberry (C terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site EcoRI (not destroyed)
- 3′ cloning site SalI (not destroyed)
- 5′ sequencing primer pBABE 5'
- 3′ sequencing primer pBABE 3' (Common Sequencing Primers)
Resource Information
-
A portion of this plasmid was derived from a plasmid made bycOVA sequence was subcloned from pCI-neo-cOVA (Addgene #25097).
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Please note Addgene NGS found a few discrepancies in the gag (truncated) region but depositor has confirmed this does not affect plasmid function. Depositor has verified plasmid's capacity to over-express the expected gene in target cells.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pBabe_Hyg_cOVA_T2A_mStrawberry was a gift from Alec Kimmelman (Addgene plasmid # 161737 ; http://n2t.net/addgene:161737 ; RRID:Addgene_161737) -
For your References section:
Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I. Yamamoto K, Venida A, Yano J, Biancur DE, Kakiuchi M, Gupta S, Sohn ASW, Mukhopadhyay S, Lin EY, Parker SJ, Banh RS, Paulo JA, Wen KW, Debnath J, Kim GE, Mancias JD, Fearon DT, Perera RM, Kimmelman AC. Nature. 2020 May;581(7806):100-105. doi: 10.1038/s41586-020-2229-5. Epub 2020 Apr 22. 10.1038/s41586-020-2229-5 PubMed 32376951